A Comparative Study of Diospyros malabarica (Gaub) Extracts in Various Polarity-Dependent Solvents for Evaluation of Phytoconstituents and Biological Activities
Abstract:Keeping in mind the ascribed repute of Diospyros malabarica (D. malabarica), this investigation was commenced to assess the effect of diverse solvents on extraction yields, phytochemical components and antioxidant capability, and in vitro biological activities of D. malabarica for pharmaceutically active constituents to combat various infections. To screen phytochemicals both qualitatively (flavonoids, terpenoid, saponins, tannins) and quantitatively like total phenolic and flavonoid contents, Diospyros malaba… Show more
“…This approach allowed compounds of similar polarity and structure to be pooled into a fraction, which could also streamline pure compound isolation by isolating fewer compounds in the mixture. The process has been known to improve the mass recovery of each pool of compounds [ 21 , 22 ]. The extracts were assessed for antioxidant activity and inhibition against the yeast α-glucosidase.…”
Acacia saligna growing in Australia has not been fully investigated for its bioactive phytochemicals. Sequential polarity-based extraction was employed to provide four different extracts from individual parts of A. saligna. Bioactive extracts were determined using in vitro antioxidant and yeast α-glucosidase inhibitory assays. Methanolic extracts from barks, leaves, and flowers are the most active and have no toxicity against 3T3-L1 adipocytes. Compound isolation of bioactive extracts provided us with ten compounds. Among them are two novel natural products; naringenin-7-O-α-L-arabinopyranoside 2 and (3S*,5S*)-3-hydroxy-5-(2-aminoethyl) dihydrofuran-2(3H)-one 9. D-(+)-pinitol 5a (from barks and flowers), (−)-pinitol 5b (exclusively from leaf), and 2,4-di-t-butylphenol 7 are known natural products and new to A. saligna. (−)-Epicatechin 6, quercitrin 4, and myricitrin 8 showed potent antioxidant activities consistently in DPPH and ABTS assays. (−)-Epicatechin 6 (IC50 = 63.58 μM), D-(+)-pinitol 5a (IC50 = 74.69 μM), and naringenin 1 (IC50 = 89.71 μM) are the strong inhibitors against the α-glucosidase enzyme. The presence of these compounds supports the activities exerted in our methanolic extracts. The presence of 2,4-di-t-butylphenol 7 may support the reported allelopathic and antifungal activities. The outcome of this study indicates the potential of Australian A. saligna as a rich source of bioactive compounds for drug discovery targeting type 2 diabetes.
“…This approach allowed compounds of similar polarity and structure to be pooled into a fraction, which could also streamline pure compound isolation by isolating fewer compounds in the mixture. The process has been known to improve the mass recovery of each pool of compounds [ 21 , 22 ]. The extracts were assessed for antioxidant activity and inhibition against the yeast α-glucosidase.…”
Acacia saligna growing in Australia has not been fully investigated for its bioactive phytochemicals. Sequential polarity-based extraction was employed to provide four different extracts from individual parts of A. saligna. Bioactive extracts were determined using in vitro antioxidant and yeast α-glucosidase inhibitory assays. Methanolic extracts from barks, leaves, and flowers are the most active and have no toxicity against 3T3-L1 adipocytes. Compound isolation of bioactive extracts provided us with ten compounds. Among them are two novel natural products; naringenin-7-O-α-L-arabinopyranoside 2 and (3S*,5S*)-3-hydroxy-5-(2-aminoethyl) dihydrofuran-2(3H)-one 9. D-(+)-pinitol 5a (from barks and flowers), (−)-pinitol 5b (exclusively from leaf), and 2,4-di-t-butylphenol 7 are known natural products and new to A. saligna. (−)-Epicatechin 6, quercitrin 4, and myricitrin 8 showed potent antioxidant activities consistently in DPPH and ABTS assays. (−)-Epicatechin 6 (IC50 = 63.58 μM), D-(+)-pinitol 5a (IC50 = 74.69 μM), and naringenin 1 (IC50 = 89.71 μM) are the strong inhibitors against the α-glucosidase enzyme. The presence of these compounds supports the activities exerted in our methanolic extracts. The presence of 2,4-di-t-butylphenol 7 may support the reported allelopathic and antifungal activities. The outcome of this study indicates the potential of Australian A. saligna as a rich source of bioactive compounds for drug discovery targeting type 2 diabetes.
“…It is commonly cultivated in warm regions of the globe, mainly China, Korea, and other Asian countries. D. kaki exhibits a number of medicinal effects, such as powerful radical sequestration and antigen lethality in the seed [ 30 ], anti-inflammatory action in the leaves [ 31 ], anticarcinogenic, antihypertensive [ 32 ], and antidiabetic properties [ 33 ]. The goal of the current study was to develop low-cost, environmentally friendly methods for degrading reactive red 81 dye.…”
Diospyros kaki leaf extract was used in this study as a favorable basis for the synthesis of copper nanoparticles (Cu NPs). X-ray diffraction (XRD) and UV-visible spectroscopy approaches were used to characterize the biologically synthesized copper nanoparticles. The XRD analysis showed that copper nanoparticles were face-centered cubic structure. Various experimental levels like conc. of dye, concentration of Cu NPs, pH, reaction time, and temperature were optimized to decolorize reactive red 81 dye using the synthesized Cu NPs. Reactive red 81 dye was decolorized maximum using Cu NPs of 0.005 mg/L. Additionally, reactive red 81 dye was decolorized at its maximum at
pH
=
6
,
temperature
=
50
°
C
. Our study reported that chemical oxidation demand (COD) and total organic carbon (TOC) deduction efficacies were 74.56% and 73.24%. Further degradation study of reactive red 81 dye was also carried out. Cu NPs have the ability and promising potential to decolorize and degrade reactive red 81 dye found in wastewater.
“…The methanol extract of the leaves and stem bark of D. malabarica obtained by maceration have previously shown anti-diabetic activity by inhibiting α-amylase. 15 In addition, in vivo studies on the methanol extract of the leaves and stem bark of D. malabarica have shown a significant hypoglycaemic effect, 16,17 and good antioxidant activity. 10 Based on a review of previous studies, extraction using ultrasoundassisted extraction (UAE) of D. malabarica has not been reported.…”
Therefore, there is the need for a therapeutic agent that will reduce glucose absorption by inhibiting the action of carbohydrate hydrolyzing enzymes such as α-glucosidase, 2,3 inhibiting the action of the DPP-4 enzyme which plays a role in reducing glucagon secretion and stimulating insulin secretion from the pancreas, 2 and scavenging free radicals. Diabetes mellitus and its complications are associated with increased oxidative stress caused by free radicals. 3 Free radicals are compounds with unpaired electrons which make them unstable and very reactive. In order to attain a paired electron state and become stable, free radicals oxidizes biomolecules and cell organelles, thus inducing cell damage. 4 Most free radicals in the body are reactive oxygen species (ROS) consisting of superoxide anion (O2•-), alkoxyl radical (RO•) radical, hydroxyl radical (OH•), peroxyl radical (ROO•), and hydroperoxyl radical (HO2•), while nitric oxide (NO•), nitrite (NO2•), and nitrate radicals (NO3•) are termed the reactive nitrogen species (RNS). 5 Free radical activity causes physiological disturbances in cells; therefore, antioxidants are needed to neutralize or mitigate free radical levels to maintain cell physiological functions and contribute to disease prevention. Antioxidant activity protects the body against the damaging effects of oxidative stress due to hyperglycemia and can improve carbohydrate, protein and lipid metabolism and glucose absorption in people with diabetes mellitus. 6 Currently, several types of drugs are available for the treatment of diabetes including non-insulin anti-diabetic drugs such as sulfonylureas, biguanides, thiazolidinediones, α-glucosidase inhibitors, Dipeptidyl peptidase 4 (DPP-4) inhibitors, and Sodium-glucose cotransporter-2 (SGLT2) inhibitors. 7 However, the use of anti-diabetic
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.